|
|
|
|
||
Added at $19,77, additional orders in at lower levelsDefinitely bad news, and it doesn't help our theory of improving cancer outcomes by cortisol modulation. But it's a tough patient population, and the vast majority of our valuation remains. Good luck to all |
return to message board, top of board |